508.460.8822 Contact Us

Industry News

Proveris Scientific to present a poster on pMDIs at DDL26

November 30th, 2015

Proveris’ CEO, Dino Farina, will be presenting a poster (Poster #65) titled “Understanding the importance and effects of shaking on pMDI performance“. The Drug Delivery to the Lungs Conference will be held from December 9th through the 11th, 2015 at the Edinburgh International Conference Centre, Edinburgh, Scotland, UK. Please visit our DDL26 page to learn more about our involvement as a […]

Continue Reading

DDL2019
December 11, 2019 | Edinburgh, Scotland
MVIS Symposium
October 7, 2019 | Lund, Sweden
Inhalation Asia 2019
November 13, 2019 | Hong Kong

View all upcoming events

 
"Proveris Scientific Corporation provides expert support for nasal developers. They are fast, reliable and are professionals at installing of their equipment and supports in demanding challenges." Dr. Peter Svete, Head of Physical Analytics, Lek Pharmaceuticals d.d.
 
 
"Proveris provides insightful and thorough test services. We would recommend working with Proveris. Proveris has great expertise in spray analysis." Elaine Schutte, Chief Development Officer, ProFibrix
 
 
"I want to express my sincere gratitude towards Proveris and the service team for being there to make sure our study goes well. The study just completed few minutes ago and thankfully everything went well.......while we conducted SAC study. It was a great display of professionalism by Proveris." ,
 
 
"As customary, Proveris's service team provided excellent service and was able to answer my questions." ,
 
 
"Thank you for the thorough training on our new equipment. I wish more companies would implement your hands on approach when it comes to training. Thanks again." ,
 
 
“We really appreciate the creativity and work conducted at Proveris for their Test Services (Proveris by Design®). Their knowledge, experience, and insight with OINDP’s was very helpful. Thanks to the Proveris team, we have a wonderful solution that we can use for commercial products!” Mic Iwashima, NDS Division, Shin Nippon Biomedical Laboratories, Ltd
 
MENU